COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Refresh II

Purpose of Study

Evaluate the safety and performance of the CytoSorb device to decrease the incidence or severity of acute kidney injury (AKI) when used intra-operatively with the cardiopulmonary bypass in subjects undergoing cardiac surgery

Trial Status


Eligibility Criteria

18 years of age or older, scheduled for non-emergent surgical procedure requiring cardiopulmonary bypass

Duration of Participation

Approximately 30 days

Contact Name: Sara Burg, RN

Contact Phone: 515-633-3845

Contact Email: